Unlikely to cause harm — often a labeling or packaging issue.
Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).
| Distributed by / for | Glenmark Generics Inc., USA, Mahwah, NJ 07430 |
| NDC | 68462-392-30 |
| Full product label | Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392-30) and b) 90-count tablets per bottle (NDC 68462-392-90), Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430. |
| Recalling firm | Glenmark Generics Inc., USA |
| Distribution | Nationwide |
| Quantity | 591,972 bottles |
| Recall initiated | 2013-02-13 |
| Report date | 2013-03-13 |
| Recall completed | 2014-10-09 |
| Recall number | D-182-2013 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Mahwah NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗